JCB logo
Avanti Polar Lipids, Inc.
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published online 23 September 2002. doi:10.1083/jcb1587rr4
This Article
Right arrow Full Text (PDF, 249K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Alert me to new content in the JCB
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by LeBrasseur, N.
Right arrow Search for Related Content
PubMed
Right arrow Articles by LeBrasseur, N.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

© The Rockefeller University Press, 0021-9525/2002/9/1154 $5.00
The Journal of Cell Biology, Volume 158, Number 7, September 30, 2002 1154-1154


Research Roundup

Hiding telomerase from chromatin


Telomerase (green) escapes the nucleoli (red) in cancer cells (bottom).

Collins/Macmillan

Telomerase helps cancerous cells survive by extending telomeres at the end of chromosomes. According to new results from Judy Wong, Leonard Kusdra, and Kathleen Collins (University of California, Berkeley, CA), cancer cells recruit additional telomerase by setting it free from its subnuclear storage depot.

Telomerase is activated upon association of two subunits, telomerase reverse transcriptase (TERT) and telomerase RNA, into a ribonucleoprotein (RNP) complex. Collins' group tracked the active form in normal and cancerous cells by expressing GFP-labeled TERT in limiting amounts that would assemble rapidly with the RNP. This technique revealed that telomerase differed mainly in its location. "A normal cell hides telomerase, by tying it to the nucleolus," says Collins. In these cells, telomerase was concentrated in the nucleoplasm during S phase, when its activity is required to maintain chromosome ends. In contrast, transformed cells released all of their telomerase from the nucleoli, regardless of cell cycle phase.

The proteins that control telomerase localization are not yet known, but the ability of transformed cells to bypass this regulation may give them a twofold advantage. First, telomerase would be more effective on an established telomere because more of it is released from nucleolar stores. Additionally, continuous release of telomerase may support the high genomic instability of cancerous cells: adding telomeres to broken chromosome ends might allow normal segregation of rearranged chromosomes that might otherwise arrest the cell cycle. {blacksquare}

Reference:

Wong, J.M.Y., et al. 2002. Nat. Cell Biol. 4:731–736.[CrossRef][Medline]



Nicole LeBrasseur

lebrasn{at}rockefeller.edu


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?



This Article
Right arrow Full Text (PDF, 249K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Alert me to new content in the JCB
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by LeBrasseur, N.
Right arrow Search for Related Content
PubMed
Right arrow Articles by LeBrasseur, N.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?


  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents